None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Suffered a fracture- Simple fracture/ Open fractures/ Comminuted fracture Administered CQ for management of fracture (only/in combination with other medication) Provide consent to participate
Exclusion criteria
Exclusion criteria: Do not provide consent Patients with hypercalcemia, Paget disease, malignant tumors, joint dysfunction, and significant polytrauma. Patients on steroid therapy or immunosuppressants and any other medications affecting bone metabolism. Pregnant or lactating patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effectiveness of oral nutritional supplement containing Cissus Quadrangularis in fracture healing as assessed by Radiological assessment Pain Swelling Sleep disturbances.Timepoint: 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the safety and tolerability of oral nutritional supplement containing Cissus Quadrangularis by monitoring complaints and adverse events.Timepoint: 6 months | — |
Countries
India
Contacts
Joint & Bone Care Hospital